Sanofi, Regeneron Lose Bid to Overturn Amgen Win in Patent Case

Sanofi, Regeneron Lose Bid to Overturn Amgen Win in Patent Case
Robert Dawson/Amgen via AP, File

A federal judge on Tuesday refused to throw out a court verdict upholding two Amgen Inc patents related to the company's cholesterol drug, a defeat for Sanofi SA and Regeneron Pharmaceuticals Inc, which make a rival drug.



Comment
Show comments Hide Comments


Related Articles